Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
13 Oktober 2021
NhTherAguix:NH TherAguix reporte son projet d’introduction en bourse sur le marché Euronext Growth à Paris
1 Oktober 2021
NhTherAguix: NH THERAGUIX announces the enrolment in Boston of the 2 first patients in its clinical trials NANOBRAINMETS Phase II targeting brain metastasis and NANOSMART Phase Ib/II targeting pancrea
28 September 2021
NhTherAguix: NH TherAguix announces the launch of its IPO on the Euronext Growth market in Paris
13 September 2021
NH TherAguix registration document approved by Autorité des Marchés Financiers as part of planned IPO on Euronext Growth Paris
31 Mai 2021
NhTherAguix: NH TherAguix and the CHU Grenoble-Alpes announce the publication of the results of the First-In-Human phase 1 clinical trial on the combination of AGuIX with radiotherapy